A new lipoglycopeptide: telavancin

Author： Nannini Esteban C   Stryjewski Martin E  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.12, 2008-08, pp. : 2197-2207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telavancin: a novel lipoglycopeptide for serious Gram-positive infections

By Laohavaleeson Somvadee   Kuti Joseph L   Nicolau David P  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 347-357

Informa Healthcare

Access to resources Recommend Favorite

Telavancin

By Lyseng-Williamson Katherine A.   Blick Stephanie K.A.  

Drugs, Vol. 69, Iss. 18, 2009-12 ,pp. : 2607-2620

Adis International

Access to resources Recommend Favorite

New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin

By Zhanel George G.   Calic Divna   Schweizer Frank   Zelenitsky Sheryl   Adam Heather   Lagacé-Wiens Philippe R.S.   Rubinstein Ethan   Gin Alfred S.   Hoban Daryl J.   Karlowsky James A.  

Drugs, Vol. 70, Iss. 7, 2010-05 ,pp. : 859-886

Adis International

Access to resources Recommend Favorite

Telavancin: TD 6424, TD-6424

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 6, 2006-01 ,pp. : 384-388

Adis International

Access to resources Recommend Favorite

Telavancin: Artificial elevation of prothrombin time: case report

By  

Reactions Weekly, Vol. 1, Iss. 1437, 2013-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite